Article 34. Procedure for the Use of New Methods of Prevention, Diagnosis and Treatment, Pharmaceutical products, Disinfectants, and the Conduct of Biomedical Research

In health care practice, only methods of prevention, diagnosis, and treatment, medical technologies, pharmaceutical products, and disinfectants permitted for use in accordance with the procedure established by law shall be applied.

Methods of diagnosis and treatment and pharmaceutical products not yet permitted for use but under consideration in the prescribed manner may be applied in the interests of treating the patient only after obtaining his or her voluntary written consent, and in the case of treating persons under the age of fourteen, only if their life is directly endangered and with the written consent of their legal representatives.

The procedure for applying such diagnostic and treatment methods and pharmaceutical products, disinfectants, including those used abroad, as referred to in part two of this Article, shall be established by the Ministry of Health of the Republic of Uzbekistan.

Biomedical research involving human beings as subjects shall be permitted only in institutions of the State health care system, after laboratory experiments have been conducted and the written consent of the citizen has been obtained. No citizen shall be compelled to participate in biomedical research.

When obtaining a citizenʼs consent to participate in biomedical research, he or she must be provided with information about the purpose, methods, possible consequences, potential risks, duration of the research, and expected results. A citizen shall have the right to withdraw from participation in the research at any stage.

The promotion of methods of prevention, diagnosis, treatment, and pharmaceutical products that have not passed the prescribed testing, including their promotion in mass media, shall be prohibited. Violation of this provision shall entail liability as established by law.